Glatiramer Acetate 20 mg/mL (Glatiramer Acetate INJECTION, SOLUTION) 20 mg/mL

Glatiramer Acetate 20 mg/mL is a subcutaneous injection solution used for managing specific autoimmune conditions. This medication is designed to support immune system modulation and is available in a convenient 20 mg/mL strength.

Strength

20 mg/mL

Pack Size

30 BLISTER PACK in 1 CARTON (0378-6960-93) / 1 SYRINGE in 1 BLISTER PACK (0378-6960-32) / 1 mL in

Manufacturer / TM Owner

Mylan Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glatiramer Acetate 20 mg/mL is primarily used for the treatment of relapsing forms of multiple sclerosis. This medication works by modulating the immune system to reduce the frequency of relapses. People often ask, 'What is Glatiramer Acetate used for?' It is commonly prescribed to help manage symptoms and slow the progression of this chronic condition.

Side Effects

Common effects of Glatiramer Acetate 20 mg/mL may include redness, pain, or swelling at the injection site. Some individuals might experience flu-like symptoms such as fever, chills, or fatigue. These effects are generally mild and temporary, but it's important to monitor any persistent or severe reactions.

Precautions & Warnings

Glatiramer Acetate 20 mg/mL should be handled with care. Always follow the prescribed dosage and administration instructions provided by your healthcare professional. Store the medication properly to maintain its effectiveness. If you experience any unusual symptoms, consult your healthcare provider immediately.

Avoid Interactions

Glatiramer Acetate 20 mg/mL may interact with other medications, including those that affect the immune system. It's important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Always consult your healthcare provider before starting or stopping any medication.

References

Frequently Asked Questions

Glatiramer Acetate is used to treat relapsing forms of multiple sclerosis by modulating the immune system.

Glatiramer Acetate 20 mg/mL is typically administered via subcutaneous injection, following the instructions provided by your healthcare professional.

Common side effects may include redness, pain, or swelling at the injection site, as well as flu-like symptoms such as fever, chills, or fatigue.

It's important to consult your healthcare provider about potential interactions with other medications before taking Glatiramer Acetate.

Store Glatiramer Acetate 20 mg/mL as directed by your healthcare provider to maintain its effectiveness.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.